GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's. PLoS One. 2012; 7(11): e50630

[This corrects the article on p. e50630 in vol. 7.].

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2013, Vol.8 (6)
Hauptverfasser:	Alters, Susan E, McLaughlin, Bryant, Spink, Benjamin, Lachinyan, Tigran, Wang, Chia-Wei, Podust, Vladimir, Schellenberger, Volker, Stemmer, Willem P C
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Crohn Disease - blood Crohn Disease - drug therapy Disease Models, Animal Glucagon-Like Peptide 2 - pharmacokinetics Glucagon-Like Peptide 2 - therapeutic use Half-Life Indomethacin - pharmacokinetics Indomethacin - therapeutic use Intestine, Small - drug effects Rats Recombinant Fusion Proteins - pharmacokinetics Recombinant Fusion Proteins - therapeutic use Tissue Distribution
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	[This corrects the article on p. e50630 in vol. 7.].
ISSN:	1932-6203
DOI:	10.1371/annotation/5c7138bd-5602-466d-8daf-e75e0b7d7fdb